^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    Signal-C®

    Company:
    Universal DX
    Type:
    Laboratory Developed Test
    Related tests:

    Details

    Evidence
    News
    Signal-C, accurately detects colorectal cancer with sensitivity of 93% and specificity of 92%. Signal-C is focused on the detection of pre-cancerous lesions (Advanced Adenomas), with 54% sensitivity and 92% specificity. This is an important differentiating factor that allows Signal-C not only to detect cancer but to prevent it.
    Cancer:
    Colorectal Cancer
    Method:
    Circulating tumor DNA (ctDNA)